In recent years, several reports revealed that LGR-5 overexpression was observed in various tumors, such as colorectal tumors [10], ovarian tumors [11], basal cell carcinoma [12], and esophageal adenocarcinoma [14]. This evidence concerns the gene LGR5 and ovarian neoplasm.